Back to Authors

Skipper, Lisa

https://orcid.org/0000-0002-1524-9787

A5079389192 | I2801572250

Mayo Clinic

From the Department of Population Genetics, Genome Institute of Singapore (Drs. Skipper, Bonnard, Kolatkar, and Liu); Department of Neurology, Singapore General Hospital (Drs. Shen, Zhao, Yuen, and E. Tan, E. Chua, K.Y. Puong); Division of Research, SingHe

Citations 2

Analysis of LRRK2 functional domains in nondominant Parkinson disease

Neurology | July 12, 2006 | Volume: 65 | Issue: 8 | Pages: 1319-1321

10.1212/01.wnl.0000180517.70572.37 | PMID 16247070

Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP

Science | July 27, 2002 | Volume: 293 | Issue: 5534 | Pages: 1487-1491

10.1126/science.1058189 | PMID 11520987

JNPL3 transgenic mice expressing a mutant tau protein, which develop neurofibrillary tangles and progressive motor disturbance, were crossed with Tg2576 transgenic mice expressing mutant β-amyloid precursor protein (APP), thus modulating the APP-Aβ (β-amyloid peptide) environment. The resulting double mutant (tau/APP) progeny and the Tg2576 parental strain developed Aβ deposits at the same age; however, relative to JNPL3 mice, the double mutants exhibited neurofibrillary tangle pathology that was substantially enhanced in the limbic system and olfactory cortex. These results indicate that either APP or Aβ influences the formation of neurofibrillary tangles. The interaction between Aβ and tau pathologies in these mice supports the hypothesis that a similar interaction occurs in Alzheimer's disease.